<DOC>
	<DOC>NCT00737347</DOC>
	<brief_summary>The purpose of the study is to investigate the effectiveness of three lifestyle treatment programs varying in level of intensiveness on prevention of pioglitazone-induced weight gain and to measure the composition of the change in body weight.</brief_summary>
	<brief_title>Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone</brief_title>
	<detailed_description>The three lifestyle interventions were usual care (1 visit), standard care (4 total visits) and intensive care (10 total visits)</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>type 2 diabetes with BMI 27 or greater, glycated hemoglobin 7% or greater insulin treated</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>obesity</keyword>
	<keyword>weight gain</keyword>
	<keyword>thiazolidinediones</keyword>
</DOC>